欧洲人群中循环25-羟基维生素D代谢物与2型糖尿病的关联:荟萃分析与孟德尔随机化分析
该研究通过荟萃分析全基因组关联研究(N=120,618)和孟德尔随机化分析,发现观察性研究中总25(OH)D水平每升高1个标准差与2型糖尿病风险降低20%相关(RR=0.80),但遗传预测的25(OH)D升高与2型糖尿病无显著因果关联(OR=0.96),不支持维生素D补充用于预防2型糖尿病。
要点
- 观察性关联:25(OH)D每升高1-SD与T2D风险降低20%相关(RR=0.80)。
- 孟德尔随机化未发现遗传预测的25(OH)D与T2D存在因果关联(OR=0.96)。
- 不支持使用维生素D补充剂预防2型糖尿病。
核心结论
- 基于孟德尔随机化分析,不支持总25(OH)D或其代谢物与2型糖尿病存在因果关联。
研究设计与样本
- 对欧洲人群全基因组关联研究进行荟萃分析,总25(OH)D样本量120,618,25(OH)D3和C3-epi-25(OH)D3样本量均为40,562。
- 利用遗传变异进行孟德尔随机化分析,包括80,983例2型糖尿病病例和842,909例非病例。
- 对既往研究和EPIC-InterAct研究结果进行随机效应荟萃分析以评估观察性关联。
主要发现
- 观察性荟萃分析中,25(OH)D每升高1-SD与T2D风险降低20%相关(RR=0.80,95%CI 0.77-0.84,p<0.001)。
- 孟德尔随机化分析中,遗传预测的25(OH)D每升高1-SD与T2D无显著关联(OR=0.96,95%CI 0.89-1.03,p=0.23)。
- 在EPIC-InterAct中,25(OH)D3每升高1-SD与T2D风险降低相关(RR=0.81,95%CI 0.77-0.86,p<0.001),C3-epi-25(OH)D3高于定量下限与T2D风险正相关(RR=1.12,95%CI 1.03-1.22,p=0.006)。
- 孟德尔随机化分析中,25(OH)D3(OR=0.97,95%CI 0.93-1.01,p=0.14)和C3-epi-25(OH)D3(OR=0.98,95%CI 0.93-1.04,p=0.53)均与T2D无因果关联。
临床怎么用
- 临床应谨慎解读维生素D与2型糖尿病的观察性关联,不应据此推荐维生素D补充用于T2D预防。
局限性
- 缺乏非线性孟德尔随机化分析。
- 研究结果基于欧洲人群,推广至其他种族人群的普适性有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Prior research suggested a differential association of 25-hydroxyvitamin D (25(OH)D) metabolites with type 2 diabetes (T2D), with total 25(OH)D and 25(OH)D3 inversely associated with T2D, but the epimeric form (C3-epi-25(OH)D3) positively associated with T2D. Whether or not these observational associations are causal remains uncertain. We aimed to examine the potential causality of these associations using Mendelian randomisation (MR) analysis. METHODS AND FINDINGS: We performed a meta-analysis of genome-wide association studies for total 25(OH)D (N = 120,618), 25(OH)D3 (N = 40,562), and C3-epi-25(OH)D3 (N = 40,562) in participants of European descent (European Prospective Investigation into Cancer and Nutrition [EPIC]-InterAct study, EPIC-Norfolk study, EPIC-CVD study, Ely study, and the SUNLIGHT consortium). We identified genetic variants for MR analysis to investigate the causal association of the 25(OH)D metabolites with T2D (including 80,983 T2D cases and 842,909 non-cases). We also estimated the observational association of 25(OH)D metabolites with T2D by performing random effects meta-analysis of results from previous studies and results from the EPIC-InterAct study. We identified 10 genetic loci associated with total 25(OH)D, 7 loci associated with 25(OH)D3 and 3 loci associated with C3-epi-25(OH)D3. Based on the meta-analysis of observational studies, each 1-standard deviation (SD) higher level of 25(OH)D was associated with a 20% lower risk of T2D (relative risk [RR]: 0.80; 95% CI 0.77, 0.84; p < 0.001), but a genetically predicted 1-SD increase in 25(OH)D was not significantly associated with T2D (odds ratio [OR]: 0.96; 95% CI 0.89, 1.03; p = 0.23); this result was consistent across sensitivity analyses. In EPIC-InterAct, 25(OH)D3 (per 1-SD) was associated with a lower risk of T2D (RR: 0.81; 95% CI 0.77, 0.86; p < 0.001), while C3-epi-25(OH)D3 (above versus below lower limit of quantification) was positively associated with T2D (RR: 1.12; 95% CI 1.03, 1.22; p = 0.006), but neither 25(OH)D3 (OR: 0.97; 95% CI 0.93, 1.01; p = 0.14) nor C3-epi-25(OH)D3 (OR: 0.98; 95% CI 0.93, 1.04; p = 0.53) was causally associated with T2D risk in the MR analysis. Main limitations include the lack of a non-linear MR analysis and of the generalisability of the current findings from European populations to other populations of different ethnicities. CONCLUSIONS: Our study found discordant associations of biochemically measured and genetically predicted differences in blood 25(OH)D with T2D risk. The findings based on MR analysis in a large sample of European ancestry do not support a causal association of total 25(OH)D or 25(OH)D metabolites with T2D and argue against the use of vitamin D supplementation for the prevention of T2D.
引用
- Zheng JS, Luan J, Sofianopoulou E, et al. The association between circulating 25-hydroxyvitamin D metabolites and type 2 diabetes in European populations: A meta-analysis and Mendelian randomisation analysis. PLoS Med. 2020. PMID: 33064751. doi:10.1371/journal.pmed.1003394
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。